相似文献
1
Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.
Antimicrob Agents Chemother. 2011 Jun;55(6):3022-4. doi: 10.1128/AAC.01732-10. Epub 2011 Mar 14.
2
Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
Int J Antimicrob Agents. 2015 Dec;46(6):696-702. doi: 10.1016/j.ijantimicag.2015.07.017. Epub 2015 Sep 7.
3
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7. doi: 10.1128/AAC.00834-10. Epub 2010 Sep 20.
4
Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
Virulence. 2018 Dec 31;9(1):930-942. doi: 10.1080/21505594.2018.1460187.
5
Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine.
Antimicrob Agents Chemother. 2012 Jan;56(1):59-69. doi: 10.1128/AAC.05191-11. Epub 2011 Oct 24.
6
Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
Acta Microbiol Immunol Hung. 2024 Jun 5;71(2):134-139. doi: 10.1556/030.2024.02268. Print 2024 Jul 2.
7
Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.
Antimicrob Agents Chemother. 2014 May;58(5):2972-5. doi: 10.1128/AAC.02642-13. Epub 2014 Feb 24.
8
Colistin Resistance in MDR-ZJ06 Revealed by a Multiomics Approach.
Front Cell Infect Microbiol. 2017 Feb 22;7:45. doi: 10.3389/fcimb.2017.00045. eCollection 2017.
9
Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii.
Microb Genom. 2019 Feb;5(2). doi: 10.1099/mgen.0.000246. Epub 2019 Feb 5.
10
In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
Yonsei Med J. 2015 Jul;56(4):928-34. doi: 10.3349/ymj.2015.56.4.928.
引用本文的文献
1
Synergistic action between peptide-neomycin conjugates and polymyxin B against multidrug-resistant gram-negative pathogens.
Front Microbiol. 2025 Aug 7;16:1605813. doi: 10.3389/fmicb.2025.1605813. eCollection 2025.
2
Inter- and intra-bacterial strain diversity remains the "elephant in the (living) room".
NPJ Antimicrob Resist. 2025 Jul 25;3(1):67. doi: 10.1038/s44259-025-00138-8.
3
Large-scale genomic analysis reveals significant role of insertion sequences in antimicrobial resistance of .
mBio. 2025 Mar 12;16(3):e0285224. doi: 10.1128/mbio.02852-24. Epub 2025 Feb 20.
4
The Evolution of Antimicrobial Resistance in and New Strategies to Fight It.
Antibiotics (Basel). 2025 Jan 14;14(1):85. doi: 10.3390/antibiotics14010085.
5
Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant Infections.
Pathogens. 2024 Nov 28;13(12):1049. doi: 10.3390/pathogens13121049.
6
Molecular epidemiology of carbapenem-resistant group in Taiwan.
mSphere. 2025 Jan 28;10(1):e0079324. doi: 10.1128/msphere.00793-24. Epub 2024 Dec 31.
7
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections.
Drugs. 2025 Jan;85(1):21-40. doi: 10.1007/s40265-024-02104-6. Epub 2024 Nov 28.
8
The Challenge of Treating Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.
Drugs. 2024 Dec;84(12):1519-1539. doi: 10.1007/s40265-024-02102-8. Epub 2024 Oct 28.
9
Colistin: Lights and Shadows of an Older Antibiotic.
Molecules. 2024 Jun 21;29(13):2969. doi: 10.3390/molecules29132969.
10
Treatment Strategies of Colistin Resistance Infections.
Antibiotics (Basel). 2024 May 6;13(5):423. doi: 10.3390/antibiotics13050423.
本文引用的文献
1
A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla(OXA-23) gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii.
Antimicrob Agents Chemother. 2011 Jan;55(1):361-3. doi: 10.1128/AAC.01672-09. Epub 2010 Oct 11.
2
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7. doi: 10.1128/AAC.00834-10. Epub 2010 Sep 20.
3
DDE transposases: Structural similarity and diversity.
Adv Drug Deliv Rev. 2010 Sep 30;62(12):1187-95. doi: 10.1016/j.addr.2010.06.006. Epub 2010 Jul 6.
4
Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii.
J Antimicrob Chemother. 2010 Jun;65(6):1162-70. doi: 10.1093/jac/dkq095. Epub 2010 Apr 7.
5
Prevalence and spread of integron-IS26 in imipenem-resistant Acinetobacter baumannii clinical isolates in South Korea.
Int J Antimicrob Agents. 2009 Dec;34(6):612-4. doi: 10.1016/j.ijantimicag.2009.06.030. Epub 2009 Sep 6.
6
Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9.
Antimicrob Agents Chemother. 2009 Sep;53(9):4045-7. doi: 10.1128/AAC.00292-09. Epub 2009 Jun 29.
7
Acinetobacter baumannii: emergence of a successful pathogen.
Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.
8
IS4 family goes genomic.
BMC Evol Biol. 2008 Jan 23;8:18. doi: 10.1186/1471-2148-8-18.
9
New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis.
Genes Dev. 2007 Mar 1;21(5):601-14. doi: 10.1101/gad.1510307.
10
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii.
Clin Microbiol Infect. 2006 Feb;12(2):123-30. doi: 10.1111/j.1469-0691.2005.01320.x.
Zotero 插件